PLEASANTON, Calif., Dec. 13, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a new non-peer-reviewed study has independently ...
10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge platform ...
The new Xenium In Situ platform enables high-throughput subcellular mapping of 100s of RNA targets in a single tissue section, revealing new insights into cellular structure and function. The Xenium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback